Company Monitoring Page for Astellas

latest headlines for company on cafepharma

July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs, hirings, Astellas, Pfizer, Eikon Therapeutics, Bayer, Avadel Pharma, Heron Therapeutics, Adverum Biotechnologies, Biogen, Eisai, X4 Pharmaceuticals, Assembly Biosciences
Astellas Pharma Plans to Open New Biotech Facility in California
Xtalks
Fri, 07/29/22 - 09:56 am
Tags:
Astellas, R&D, California, San Francisco
Seagen, Astellas claim positive results in study key to cancer drug's success
BioPharma Dive
Tue, 07/26/22 - 11:26 am
Tags:
Seagen, Astellas, Padcev, Merck, Keytruda, bladder cancer, clinical trials
Astellas to Open New Biotech Campus in South San Francisco
Contract Pharma
Fri, 07/22/22 - 10:16 am
Tags:
Astellas, San Francisco, biotech, California
Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Pharmaceutical Business Review
Tue, 07/5/22 - 11:08 am
Tags:
Mogrify, Astellas, regenerative medicine, hearing loss
Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Tue, 06/28/22 - 10:35 am
Tags:
Astellas, Sutro BioPharma, antibody-drug conjugate, cancer, immuno-oncology
FDA Presses Pause on Astellas' Pompe Disease Therapeutic
BioSpace
Mon, 06/27/22 - 10:07 am
Tags:
Astellas, Pompe disease, clinical trials, FDA, AT845
Astellas, despite recent setbacks, opens $100M gene therapy plant
BioPharma Dive
Wed, 06/8/22 - 11:05 pm
Tags:
Astellas, gene therapy, drug manufacturing, North Carolina
GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Tags:
Astellas, immuno-oncology, R&D, Go Therapeutics, glycoprotein targets
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysis
Fierce Pharma
Thu, 05/19/22 - 10:32 am
Tags:
Astellas, roxadustat, FibroGen, ERA, erythropoietin
Astellas, Twist Join Forces to Enhance Tumor Immunity
BioSpace
Tue, 05/10/22 - 10:38 pm
Tags:
Astellas, Twist Bioscience, R&D, antibodies, tumor immunity
Astellas, Tmunity, Underscore Rocky Terrain of CAR-T and Gene Therapies
BioSpace
Mon, 04/25/22 - 10:38 pm
Tags:
Astellas, Tmunity, CAR-T, gene therapy, myotubular myopathy
Astellas takes $170m charge as it drops DMD gene therapies
Pharmaforum
Fri, 04/22/22 - 10:48 am
Tags:
Astellas, gene therapy, Duchenne Muscular Dystrophy, earnings
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
Tags:
AACR, Bicycle Therapeutics, Rubius Therapeutics, C4 Therapeutics, Zentalis, Affimed, Seagen, Astellas
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Fierce Biotech
Tue, 03/15/22 - 10:41 am
Tags:
Astellas, menopause, hot flashes, clinical trials, fezolinetant
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Pharmaforum
Mon, 03/7/22 - 10:07 am
Tags:
Astellas, menopause, clinical trials, fezolinetant, hot flashes
March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter?
Fierce Pharma
Tue, 02/22/22 - 11:17 pm
Tags:
Pfizer, Astellas, prostate cancer, Xtandi, NIH
Trial win sets up new use for Astellas, Seagen’s Padcev in bladder cancer
Pharmaforum
Mon, 02/14/22 - 11:44 pm
Tags:
Astellas, Seagen, Padcev, bladder cancer, clinical trials
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta
Fierce Biotech
Wed, 12/1/21 - 11:51 pm
Tags:
Astellas, Dyno Therapeutics, biobucks, gene therapy
ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J
Fierce Pharma
Sat, 09/18/21 - 08:25 pm
Tags:
ESMO, Pfizer, Astellas, Xtandi, prostate cancer, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.